IntrinsicIntrinsic
← Scroll for more →

Financial Statements — UG

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents2.390.741.250.861.771.271.882.448.417.078.247.126.481.200.830.500.360.510.530.69
Short-term Investments7.207.307.327.446.656.857.527.051.451.540.850.930.945.775.656.666.417.287.648.89
Accounts Receivable1.692.011.591.161.911.551.431.491.682.131.571.821.541.481.431.132.112.551.811.93
Inventory1.181.321.511.411.531.501.451.191.171.281.221.231.782.471.672.291.731.501.411.29
Total Current Assets12.7111.8112.2011.2512.4711.6912.6712.4813.1412.4312.2511.6211.3611.249.9710.8711.0812.3111.5812.96
Property, Plant & Equipment0.880.890.910.920.930.930.960.670.660.620.620.560.510.540.560.620.600.630.660.66
Total Non-current Assets*0.880.890.910.930.931.071.130.770.690.620.670.560.510.700.670.800.600.630.660.66
Total Assets13.5912.7013.1112.1813.3912.7613.8013.2513.8313.0512.9212.1711.8811.9410.6411.6811.6812.9412.2413.63
Accounts Payable0.500.110.480.240.420.380.430.510.340.420.130.170.160.440.030.100.420.370.410.09
Total Current Liabilities1.741.471.671.601.851.931.911.881.711.861.531.471.351.921.371.661.982.012.341.71
Total Non-current Liabilities*0.220.330.210.000.080.000.000.000.000.020.000.050.040.000.000.000.030.200.080.23
Total Liabilities*1.961.801.881.601.931.931.911.881.711.881.531.521.391.921.371.662.022.212.421.93
Retained Earnings11.1710.4410.7710.1211.0010.3811.4210.9211.6610.7110.9310.1910.029.568.819.559.2110.279.3611.23
Total Stockholder Equity11.6310.9011.2310.5811.4610.8411.8811.3812.1211.1711.3910.6510.4810.029.2710.019.6710.739.8211.69
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue3.112.872.962.262.842.482.483.063.393.252.613.062.652.572.762.423.633.893.663.18
Cost of Revenue1.561.451.631.311.341.121.201.411.561.561.211.751.431.091.521.081.691.711.571.32
Gross Profit1.551.421.330.951.501.361.281.651.831.701.401.311.221.481.251.341.932.182.091.86
Research & Development0.120.120.120.120.110.110.130.110.110.100.110.100.130.130.130.120.110.130.130.13
Total Operating Expenses0.790.780.610.740.800.750.730.700.710.670.610.590.700.640.600.650.730.680.740.59
Operating Income0.750.640.720.220.700.610.560.951.111.030.790.720.520.830.650.691.201.501.361.27
Pretax Income0.921.030.820.330.790.710.641.101.211.170.930.790.580.950.840.430.801.151.401.28
Tax Provision0.190.210.170.060.160.150.140.230.250.240.190.160.120.200.170.090.170.240.290.27
Net Income0.730.820.650.270.630.560.500.870.960.930.740.630.460.760.680.350.630.911.121.02
Basic EPS0.160.180.140.060.140.120.110.190.210.200.160.140.100.160.150.070.140.20----
Diluted EPS----------------------------------0.20----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow1.520.600.331.010.300.320.271.231.320.641.131.160.430.420.620.741.140.031.661.03
Capital Expenditures0.020.010.020.020.020.000.320.030.070.020.090.070.000.000.020.050.010.000.030.04
Free Cash Flow*1.500.590.311.000.290.32(0.05)1.201.260.621.031.100.430.420.610.691.130.021.630.99
Investing Cash Flow0.130.030.06(0.77)0.210.68(0.84)(5.58)0.01(0.67)-0.00(0.07)4.85(0.05)1.13(0.59)0.41(0.05)1.16(1.08)
Financing Cash Flow0.00(1.15)0.00(1.15)(0.01)(1.61)0.00(1.61)0.00(1.15)0.00(0.46)0.00--(1.42)0.00(1.70)--(2.99)0.00
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q2 2019Q3 2015Q2 2015Q3 2014Q2 2014Q3 2013Q2 2013Q3 2012Q2 2012
Dividends Per Share0.250.250.000.350.350.000.250.100.370.500.000.500.000.480.000.470.000.36
← Scroll for more columns →